financetom
Business
financetom
/
Business
/
Nippon Steel Execs Rally Support in Pennsylvania Amid Pushback On US Steel Takeover
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nippon Steel Execs Rally Support in Pennsylvania Amid Pushback On US Steel Takeover
Nov 19, 2024 8:30 PM

Nippon Steel ( NISTF ) executives have traveled to Pennsylvania to garner support for their $15 billion acquisition bid for U.S. Steel . The Japanese steel giant is encountering political resistance in Washington.

What Happened: Takahiro Mori, vice-chair of Nippon Steel ( NISTF ), arrived in Pittsburgh on Saturday to advocate for the acquisition. The deal faces opposition from both President Joe Biden and President-elect Donald Trump, who prefer U.S. Steel to remain under American ownership, the Financial Times reported on Tuesday.

Despite these political challenges, Nippon Steel ( NISTF ) is seeking regulatory approval post-election. Mori is scheduled to meet with government officials in Washington later this week.

Mori is also engaging with U.S. Steel workers this week, particularly those in the United Steelworkers union. Some union members have expressed support for the deal, differing from USW president David McCall, who opposes Nippon’s ownership.

See Also: Dow Tumbles Over 300 Points Following Economic Reports, Nvidia, Microsoft Decline: Fear & Greed Index Moves To ‘Neutral’ Zone

Nippon Steel ( NISTF ) has committed to investing nearly $3 billion in U.S. facilities. The Committee on Foreign Investment in the U.S. has granted Nippon a 90-day extension to address national security concerns, with a final decision anticipated by the end of the year.

Why It Matters: The acquisition of U.S. Steel by Nippon Steel ( NISTF ) has been a contentious issue, with significant political and economic implications. Nippon Steel ( NISTF ) remains optimistic about finalizing the deal by year-end, despite facing opposition from the Biden administration and President-elect Trump, who plans to block the acquisition.

The deal is seen as a potential boost for the U.S. economy by creating jobs and increasing competitiveness against China’s steel industry. However, the United Steelworkers union opposes the deal, citing job security concerns for its members.

In October, U.S. Steel reported better-than-expected third-quarter results, with earnings of 56 cents per share, surpassing analyst expectations. The company expressed its intention to close the deal with Nippon Steel ( NISTF ) by the end of the year.

Read Next:

Major Investor In Trump Media Offloads Most Of Its Stake In DJT Stock

Disclaimer: This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.

Image by Poetra.RH via Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lexaria Bioscience Hires Contract Research Organization For 12-week Study
Lexaria Bioscience Hires Contract Research Organization For 12-week Study
Jun 18, 2024
11:40 AM EDT, 06/18/2024 (MT Newswires) -- Lexaria Bioscience ( LEXX ) said Tuesday that it hired a contract research organization to manage its 12-week chronic study, GLP-1-H24-4, to evaluate different DehydraTECH-GLP-1 formulations and other treatments, focusing on goals such as weight loss and reducing blood sugar levels. Preparations for the study with the CRO have started under an initial...
Immunocore Randomizes First Patient in Phase 3 Trial of Cutaneous Melanoma Combination Treatment
Immunocore Randomizes First Patient in Phase 3 Trial of Cutaneous Melanoma Combination Treatment
Jun 18, 2024
11:40 AM EDT, 06/18/2024 (MT Newswires) -- Immunocore Holdings ( IMCR ) said Tuesday it has randomized the first patient in a phase 3 clinical trial of brenetafusp in combination with nivolumab to treat first-line advanced or metastatic cutaneous melanoma, a type of skin cancer. The trial will randomize patients with first-line advanced or metastatic cutaneous melanoma to brenetafusp plus...
What's Going On With Greenwave Technology
What's Going On With Greenwave Technology
Jun 18, 2024
Greenwave Technology Solutions, Inc. ( GWAV ) shares are trading higher Tuesday after the company announced the completion of its recapitalization. The Details: Greenwave said it has strengthened its balance sheet by approximately $80.5 million since February and has a current cash balance of over $26 million, its strongest cash position in company history.  The company also said it is...
What's Going On With Mustang Bio Stock Tuesday?
What's Going On With Mustang Bio Stock Tuesday?
Jun 18, 2024
Mustang Bio, Inc. ( MBIO ) shares appear to be trending upward Tuesday on continued momentum after the company on Monday announced safety and efficacy data from its Phase 1/2 clinical trial of MB-106, a possible treatment for certain types of blood cancer. 90% of patients treated with MB-106 responded to the treatment with three complete responses. Out of the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved